PTC THERAPEUTICS, INC. — Director's Dealing 2021

Jan 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-06

Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-06	Common Stock	A	27600	—	Acquired	82283	Direct
2021-01-06	Common Stock	A	3960	—	Acquired	15714	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-06	Stock Option (Right to Buy)	$66.49	A	161000	Acquired	2031-01-05	Common Stock (161000)	Direct
2021-01-06	Stock Option (Right to Buy)	$66.49	A	23100	Acquired	2031-01-05	Common Stock (23100)	Indirect

Footnotes

F1: Restricted stock units granted on January 6, 2021 that vest in four equal installments over four years, commencing on January 6, 2022.

F2: This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.